Paola’s study demonstrated that when cancer cells are stimulated with pro-ICD (immunogenic cell death) drugs, PKR, a key mediator of eIF2 phosphorylation, can promote CTR translocation to the surface of melanoma cells by promoting cancer cell death and the release of damage-associated molecular patterns (DAMP) from dead cells [45]. The gene discussed is EIF2AK2; the disease is cancer.